| Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population SL Klein, A Pekosz, HS Park, RL Ursin, JR Shapiro, SE Benner, ... The Journal of clinical investigation 130 (11), 6141-6150, 2020 | 495 | 2020 |
| SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ... The Journal of clinical investigation 131 (5), 2021 | 252 | 2021 |
| Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers EU Patel, EM Bloch, W Clarke, YH Hsieh, D Boon, Y Eby, RE Fernandez, ... Journal of Clinical Microbiology 59 (2), 10.1128/jcm. 02257-20, 2021 | 205 | 2021 |
| SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors SE Benner, EU Patel, O Laeyendecker, A Pekosz, K Littlefield, Y Eby, ... The Journal of infectious diseases 222 (12), 1974-1984, 2020 | 116 | 2020 |
| Durable SARS-CoV-2 B cell immunity after mild or severe disease CO Ogega, NE Skinner, PW Blair, HS Park, K Littlefield, A Ganesan, ... The Journal of clinical investigation 131 (7), 2021 | 114 | 2021 |
| A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants L Jiang, TAP Driedonks, WSP Jong, S Dhakal, ... Journal of extracellular vesicles 11 (3), e12192, 2022 | 100 | 2022 |
| Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model S Dhakal, CA Ruiz-Bedoya, R Zhou, PS Creisher, JS Villano, K Littlefield, ... MBio 12 (4), 10.1128/mbio. 00974-21, 2021 | 74 | 2021 |
| Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality WR Morgenlander, SN Henson, DR Monaco, A Chen, K Littlefield, ... The Journal of clinical investigation 131 (7), 2021 | 73 | 2021 |
| Markers of polyfunctional SARS-CoV-2 antibodies in convalescent plasma H Natarajan, AR Crowley, SE Butler, S Xu, JA Weiner, EM Bloch, ... MBio 12 (2), 10.1128/mbio. 00765-21, 2021 | 62 | 2021 |
| Cytokine and chemokine levels in coronavirus disease 2019 convalescent plasma TS Bonny, EU Patel, X Zhu, EM Bloch, MK Grabowski, AG Abraham, ... Open Forum Infectious Diseases 8 (2), ofaa574, 2021 | 49 | 2021 |
| Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers CD Heaney, N Pisanic, PR Randad, K Kruczynski, T Howard, X Zhu, ... Journal of Clinical Virology 145, 104997, 2021 | 41 | 2021 |
| Pregnancy alters interleukin-1 beta expression and antiviral antibody responses during severe acute respiratory syndrome coronavirus 2 infection ML Sherer, J Lei, PS Creisher, M Jang, R Reddy, K Voegtline, S Olson, ... American journal of obstetrics and gynecology 225 (3), 301. e1-301. e14, 2021 | 37 | 2021 |
| SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy H Natarajan, AR Crowley, SE Butler, S Xu, JA Weiner, EM Bloch, ... MedRxiv, 2020 | 30 | 2020 |
| Dysregulated immunity in SARS-CoV-2 infected pregnant women ML Sherer, J Lei, P Creisher, M Jang, R Reddy, K Voegtline, S Olson, ... medRxiv, 2020.11. 13.20231373, 2020 | 29 | 2020 |
| CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ... BioRxiv, 2020 | 29 | 2020 |
| ABO blood group and SARS‐CoV‐2 antibody response in a convalescent donor population EM Bloch, EU Patel, C Marshall, K Littlefield, R Goel, BJ Grossman, ... Vox sanguinis 116 (7), 766-773, 2021 | 27 | 2021 |
| Progression and resolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in golden Syrian hamsters KR Mulka, SE Beck, CV Solis, AL Johanson, SE Queen, ME McCarron, ... The American Journal of Pathology 192 (2), 195-207, 2022 | 26 | 2022 |
| A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants I Sitaras, R Zhou, C Caputo, K Littlefield, M Lowman, M Chen, G Lima, ... J. Extracell. Vesicles 11 (3), e12192, 2022 | 21 | 2022 |
| Pharmacokinetics of high-titer anti–SARS-CoV-2 human convalescent plasma in high-risk children O Gordon, MK Brosnan, S Yoon, D Jung, K Littlefield, A Ganesan, ... JCI insight 7 (2), 2022 | 17 | 2022 |
| Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in a longitudinally sampled cohort of … AAR Antar, T Yu, N Pisanic, R Azamfirei, JA Tornheim, DM Brown, ... Open Forum Infectious Diseases 8 (6), ofab195, 2021 | 16 | 2021 |
